Enhancing Prospective Thinking in Early Recovery
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: Addiction recovery | Addiction
Age: Between 21 - 45 Years
Gender: Male or Female
Participants who have remained drug/alcohol free since treatment.
Able to understand questionnaires/procedures in English.
History of smell or taste disorders, including any special sensitivities to volatile chemicals.
History of chronic asthma (potential risk with odorants)
Medications (past 30 days) that could influence imaging data/subject safety (e.g. antidepressants, antipsychotics, benzodiazepines, etc.) as determined by the investigator, and any nasally administered non-steroidal medications.
Current pharmaceutical treatment for DSM-V diagnoses of intellectual disorders, autism, motor disorders, schizophrenia/psychotic disorders, bipolar disorders, major depressive disorders, generalized anxiety, panic, agoraphobia, or claustrophobia, obsessive compulsive and related disorders, post-traumatic or acute stress disorders, associative disorders, somatic symptom disorders, feeding/eating disorders, sleep/wake disorders, medication-induced movement disorders, or neurocognitive disorders, as determined by investigator.
Disorders or history of neurological disease or cerebral origin, or head injury with > 20 min loss of consciousness.
Positive breath alcohol readings or urine screen result during initial screening or study day visit (but not follow-up) will result in exclusion or disqualification.
Inability (per investigator assessment or language ability) to follow instructions/study procedures.
Any condition that, in the judgment of the PI or study physicians, could place the subject at risk or affect data validity.
Left-handed people will be excluded from imaging, as left-handed people show different brain activation patterns than right-handed people.